FINWIRES · TerminalLIVE
FINWIRES

Etern Experiences Unusual Stock Movement; Shares Up 3%

By

Jiangsu Etern (SHA:600105) experienced abnormal stock fluctuations for three consecutive trading days, but the company said its operations were normal, according to a Shanghai bourse filing on Friday.

The company's closing stock price rose more than 20% between June 2 and 4, exceeding the bourse's threshold.

The company's probe found that it does not have any material changes or significant disclosure that could affect the share price.

The Chinese telecommunication cable and wire manufacturer's shares rose 3% during the afternoon trade.

Related Articles

Asia

Tongding Interconnection Information Completes Registration of Two Units; Shares Down 5%

Tongding Interconnection Information (SHE:002491) completed the registration for two new companies in Shaoguan's Qujiang District in Guangdong, China.Tongding Optical Shaoguan, with 800 million yuan in registered capital, and Tongding Information Communication Shaoguan, with 100 million yuan in capital, will produce 600 tons of fiber preform and 20 million core-kilometers of optical fiber annually, according to a Friday filing with the Shenzhen bourse.Shares of the industrial automation equipment manufacturer closed 5% in recent trade.

$SHE:002491
Asia

Treasury Wine Estates' Wind-Down of Non-Core Brands Brings Both Cost, Complexity, Jarden Says

Treasury Wine Estates (ASX:TWE) has a lot of work to do, particularly around the wind-down of non-core brands, which brings both costand complexity, Jarden said in a Thursday note.It has made short-term decisions to the detriment of the business long-term, Jarden said, compounded by US distributor issues and regulations in China. However, its new Chief Executive is taking decisive action and a customer-led approach, rebuilding trust in the supply chain. The firm seeks to rationalize its portfolio from around 76 brands to fewer than 30.The firm expected fiscal year 2026 earnings before interest, tax, material items, and self-generating and regenerating assets (EBITS) to reach AU$480 million to AU$490 million, 1% above consensus. Fiscal 2027 guidance was broadly in line with consensus, with management targeting at least equivalent performance.Jarden forecast fiscal 2026 EBITS of AU$487 million, at the higher end of the guidance range, but trimmed its fiscal year 2027 to fiscal year 2028 forecasts by around 5% to 6%.The investment firm retained its overweight rating on Treasury Wine Estates and its AU$5 per share price target.

$ASX:TWE
Asia

Keymed Biosciences Receives $257 Million Upfront Payment After Gilead-Ouro Deal Close

Keymed Biosciences (HKG:2162) received an upfront payment of $257 million following the completion of Gilead Sciences' acquisition of Ouro Medicines, according to a Friday Hong Kong bourse filing.Under the transaction, Gilead acquired all equity interests in Ouro Medicines for an upfront payment of $1.68 billion and potential milestone payments of up to $500 million.The company said its existing licensing agreement with Ouro Medicines remains in effect, preserving its eligibility for up to $610 million in development and commercial milestones, as well as tiered royalties on net sales.

$HKG:2162